Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nima Sharifi

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Endocrinology|July 5, 2019
HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and BeyondNavin Sabharwal, Nima Sharifi
European Urology|June 25, 2016
Could Steroidal Abiraterone Metabolites Possibly Explain Abiraterone Withdrawal Syndrome?Orazio Caffo, Nima Sharifi
Urology|September 1, 2020
Germline HSD3B1 Genetics and Prostate Cancer OutcomesLewis Thomas, Nima Sharifi
Steroids|April 17, 2012
Steroid biosynthesis and prostate cancerNima Sharifi, Richard J Auchus
Endocrine-Related Cancer|April 18, 2020
Androgen hazards with COVID-19Nima Sharifi, Charles J Ryan
Annual Review of Medicine|October 16, 2019
Sex Hormones and Prostate CancerRichard J Auchus, Nima Sharifi
Cancer Biology & Therapy|September 21, 2007
Androgen receptor modulation: lessons learned from beyond the prostateNima Sharifi, William D Figg
The New England Journal of Medicine|March 25, 2005
Vascular events after acute infection or vaccinationNima Sharifi, Pirooz S Mofrad
American Journal of Epidemiology|March 18, 2008
Re: "Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women's health initiative (United States)"Nima Sharifi, William L Farrar
American Journal of Therapeutics|April 29, 2006
Androgen receptor as a therapeutic target for androgen independent prostate cancerNima Sharifi, William L Farrar
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Endocrinology|July 5, 2019
HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and BeyondNavin Sabharwal, Nima Sharifi
European Urology|June 25, 2016
Could Steroidal Abiraterone Metabolites Possibly Explain Abiraterone Withdrawal Syndrome?Orazio Caffo, Nima Sharifi
Urology|September 1, 2020
Germline HSD3B1 Genetics and Prostate Cancer OutcomesLewis Thomas, Nima Sharifi
Steroids|April 17, 2012
Steroid biosynthesis and prostate cancerNima Sharifi, Richard J Auchus
Endocrine-Related Cancer|April 18, 2020
Androgen hazards with COVID-19Nima Sharifi, Charles J Ryan
Annual Review of Medicine|October 16, 2019
Sex Hormones and Prostate CancerRichard J Auchus, Nima Sharifi
Cancer Biology & Therapy|September 21, 2007
Androgen receptor modulation: lessons learned from beyond the prostateNima Sharifi, William D Figg
The New England Journal of Medicine|March 25, 2005
Vascular events after acute infection or vaccinationNima Sharifi, Pirooz S Mofrad
American Journal of Epidemiology|March 18, 2008
Re: "Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women's health initiative (United States)"Nima Sharifi, William L Farrar
American Journal of Therapeutics|April 29, 2006
Androgen receptor as a therapeutic target for androgen independent prostate cancerNima Sharifi, William L Farrar
Pageof 17